Annual General Meeting of Curatis Holding AG Approves All Proposals

Curatis Holding AG held its Annual General Meeting in Liestal, Switzerland, on June 21, 2024. The shareholders of the specialty pharmaceutical and therapeutic drug development company, listed on the SIX Swiss Exchange, voted in favour of all proposals put forth by the Board of Directors.

The approved resolutions included the annual report and financial statements for the year 2023, the appointment of Forvis Mazars as the new auditor, and board and management compensation. Shareholders also accepted selected changes to the articles of association by significant majorities.

With 85.43% of voting rights represented, the shareholders re-elected Marian Borovsky (Chairman, independent), Günter Graubach, Roland Rutschmann, and Silvio Inderbitzin (independent) to the Board of Directors for another one-year term. Members of the compensation committee—Marian Borovsky, Roland Rutschmann, and Günter Graubach—were similarly re-elected for a year.